Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood|June 22, 2010
The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responsesIain Comerford, Robert J B Nibbs, Wendel Litchfield, et al.
Immunology and Cell Biology|July 17, 2014
The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMTYuka Harata-Lee, Michelle E Turvey, Julie A Brazzatti, et al.
Frontiers in Oncology|May 21, 2019
Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell LinesSaeed Nourmohammadi, Thazin Nwe Aung, Jian Cui, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 19, 2010
An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune diseaseIain Comerford, Mark Bunting, Kevin Fenix, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 17, 2019
An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancerJue Zhang, Zhipeng Qu, Hong Yao, et al.
Heliyon|January 23, 2025
A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagyJue Zhang, Zhipeng Qu, Xi Xiao, et al.
The Journal of Experimental Medicine|April 15, 2020
ACKR4 restrains antitumor immunity by regulating CCL21Carly E Whyte, Maleika Osman, Ervin E Kara, et al.
Pharmacological Research|January 25, 2022
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional reviewCherry L Wainwright, Mauro M Teixeira, David L Adelson, et al.
Pageof 2